PuSH - Publication Server of Helmholtz Zentrum München

69 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Osterhoff, M.A.* et al.: Specific phospholipids are differently associated to human visceral and non-visceral adipose tissue depending on the inflammatory state in the NUGAT Twin study. Diabetologia 59, S67-S67 (2016)
42.
Randrianarisoa, E. et al.: Relationship of serum trimethylamine n-oxide (TMAO) levels with early atherosclerosis in humans. Sci. Rep. 6:26745 (2016)
43.
Siegel-Axel, D. et al.: The interplay of fatty liver with fatty pancreas accenuates local islet inflammation in humans. Diabetologia 59, S79-S79 (2016)
44.
Böhm, A. et al.: Reduced and adverse metabolic response to supervised 8-week endurance exercise in a group at high risk for type 2 diabetes. Diabetologia 58, S258 (2015)
45.
Bongers, M.N.* et al.: Lebervolumen, Leberfettanteil und Körpergewicht im Verlauf einer Lebensstilinterventionsstudie : Eine Analyse mit quantitativen MR-basierten Methoden. Radiologe 55, 323-328 (2015)
46.
Kächele, M.* et al.: Variation in the phosphoinositide 3-kinase gamma gene affects plasma HDL-cholesterol without modification of metabolic or inflammatory markers. PLoS ONE 10, DOI: 10.1371/journal.pone.0144494 (2015)
47.
Kullmann, S. et al.: Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38, 1044-1050 (2015)
48.
Stefan, N. et al.: A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 58, 2877-2884 (2015)
49.
Wagner, R. et al.: SNP x SNP interactions in the VPS13C/C2CD4A/C2CD4B locus modulate diabetes risk. Diabetologia 58, S142 (2015)
50.
Linder, K. et al.: Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity 13, 733-748 (2014)
51.
Lutz, S.Z. et al.: Common genetic variation in the human CTF1 locus, encoding cardiotrophin-1, determines insulin sensitivity. PLoS ONE 9:e100391 (2014)
52.
Sartorius, T. et al.: Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity. PLoS ONE 9:e92358 (2014)
53.
Silbernagel, G.* ; Machann, J. ; Häring, H.-U. ; Fritsche, A. & Peter, A.*: Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur. J. Clin. Nutr. 68, 97-100 (2014)
54.
Stefan, N. et al.: Impact of the adipokine adiponectin and the hepatokine fetuin-a on the development of type 2 diabetes: Prospective cohort- and cross-sectional phenotyping studies. PLoS ONE 9:e92238 (2014)
55.
Stefan, N.* et al.: Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabet. Endocrinol. 2, 406-416 (2014)
56.
Stefan, N. et al.: Obesity and renal disease: Not all fat is created equal and not all obesity is harmful to the kidneys. Nephrol. Dial. Transplant., DOI: 10.1093/ndt/gfu081 (2014)
57.
Veit, R.* et al.: Reduced cortical thickness associated with visceral fat and BMI. Neuroimage: Clin. 6, 307-311 (2014)
58.
Heni, M.* et al.: Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. J. Clin. Endocrinol. Metab. 98, E1224-E1229 (2013)
59.
Kantartzis, K. et al.: The change in plasma triglycerides during an OGTT strongly predicts nonalcoholic fatty liver disease and the effectiveness of a lifestyle intervention to reduce liver fat. Diabetologia 56, S323 (2013)
60.
Lehmann, R.* et al.: Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 (2013)